Abstract
Metformin is the first-line medication to increase insulin sensitivity in insulin-resistant conditions such as type 2 diabetes, polycystic ovary syndrome, and obesity. However, metformin is a drug with a wide range of pharmacological properties, showing the ability to treat various skin conditions. Some inflammatory skin dermatoses, skin neoplasms, endocrinology-related dermatosis, pigmentary disorders, skin aging, and wound healing have all shown improvement when metformin is used. This review discusses the most recent research supporting the use of metformin as a treatment for common skin conditions.(International Journal of Biomedicine. 2022;12(4):521-525.).
| Original language | English |
|---|---|
| Pages (from-to) | 521-525 |
| Number of pages | 5 |
| Journal | International Journal of Biomedicine |
| Volume | 12 |
| Issue number | 4 |
| DOIs | |
| State | Published - Dec 2022 |
UN SDGs
This output contributes to the following UN Sustainable Development Goals (SDGs)
-
SDG 3 Good Health and Well-being
Keywords
- Metformin
- indications
- skin disorders
Fingerprint
Dive into the research topics of 'Novel Metformin Indications and Skin Disorders'. Together they form a unique fingerprint.Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver